Showing results (2131-2140 of 2,693) with videos related to

Sort By:
Pageof 270
Developmental Biology|February 19, 2008
Expression and function of Dlx genes in the osteoblast lineageHaitao Li, Inga Marijanovic, Mark S Kronenberg, et al.
The British Journal of Dermatology|July 26, 2023
Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT studyIltefat H Hamzavi, Kristen Bibeau, Pearl Grimes, et al.
Pediatric Blood & Cancer|January 21, 2006
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941)Mohammad Jarrar, Paul S Gaynon, Antonia P Periclou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2010
Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signalingDe-Zhi Tang, Wei Hou, Quan Zhou, et al.
Dalton Transactions (Cambridge, England : 2003)|May 8, 2010
A synthetic model of Hg(II) sequestrationJulie A Viehweg, Sarah M Stamps, Jennifer J Dertinger, et al.
Bone Marrow Transplantation|May 27, 2008
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndromeD Bhatla, S M Davies, S Shenoy, et al.
Sleep|January 23, 2019
Sleep and cognitive aging in the eighth decade of lifeSimon R Cox, Stuart J Ritchie, Mike Allerhand, et al.
Journal of Periodontology|August 8, 2013
Enamel matrix derivative: protein components and osteoinductive propertiesBradshaw M Stout, Brian J Alent, Peter Pedalino, et al.
Journal of Clinical Medicine|January 23, 2020
Comparative Genomic Mapping Implicates LRRK2 for Intellectual Disability and Autism at 12q12, and HDHD1, as Well as PNPLA4, for X-Linked Intellectual Disability at Xp22.31Jonathan D J Labonne, Terri M Driessen, Marvin E Harris, et al.
Eclinicalmedicine|June 14, 2024
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging studyThierry Passeron, Khaled Ezzedine, Iltefat Hamzavi, et al.
Pageof 270